Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 7
2017 143
2018 280
2019 201
2020 13
Text availability
Article attribute
Article type
Publication date

Search Results

555 results
Results by year
Filters applied: . Clear all
Page 1
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
Arbyn M, Xu L, Simoens C, Martin-Hirsch PP. Arbyn M, et al. Cochrane Database Syst Rev. 2018 May 9;5(5):CD009069. doi: 10.1002/14651858.CD009069.pub3. Cochrane Database Syst Rev. 2018. PMID: 29740819 Free PMC article. Review.
Results are presented as risks in control and vaccination groups and risk ratios (RR) with 95% confidence intervals in brackets. ...Mortality was 11/10,000 in control groups compared with 14/10,000 (9 to 22) with HPV vaccine (RR 1.29 [0.85 to 1. …
Results are presented as risks in control and vaccination groups and risk ratios (RR) with 95% confidence intervals in bracket …
Effect of cervical cancer education and provider recommendation for screening on screening rates: A systematic review and meta-analysis.
Musa J, Achenbach CJ, O'Dwyer LC, Evans CT, McHugh M, Hou L, Simon MA, Murphy RL, Jordan N. Musa J, et al. PLoS One. 2017 Sep 5;12(9):e0183924. doi: 10.1371/journal.pone.0183924. eCollection 2017. PLoS One. 2017. PMID: 28873092 Free PMC article. Review.
OBJECTIVES: The objective of this systematic review is to understand the evidence of the effect of cervical cancer education compared to control conditions on cervical cancer screening rates in eligible women population at risk of cervical cancer. ...Additionally, o …
OBJECTIVES: The objective of this systematic review is to understand the evidence of the effect of cervical cancer education compared …
Therapeutic HPV vaccines.
Hancock G, Hellner K, Dorrell L. Hancock G, et al. Best Pract Res Clin Obstet Gynaecol. 2018 Feb;47:59-72. doi: 10.1016/j.bpobgyn.2017.09.008. Epub 2017 Sep 28. Best Pract Res Clin Obstet Gynaecol. 2018. PMID: 29108943 Review.
High-risk human papillomavirus (HPV) infection is known to be a necessary factor for cervical and anogenital malignancies. Cervical cancers account for over a quarter of a million deaths annually. ...As cervical dysplasia can regress spontaneously, a therapeu …
High-risk human papillomavirus (HPV) infection is known to be a necessary factor for cervical and anogenital malignanci …
Opportunities and challenges for human papillomavirus vaccination in cancer.
Roden RBS, Stern PL. Roden RBS, et al. Nat Rev Cancer. 2018 Apr;18(4):240-254. doi: 10.1038/nrc.2018.13. Epub 2018 Mar 2. Nat Rev Cancer. 2018. PMID: 29497146 Free PMC article. Review.
The discovery of genotype 16 as the prototype oncogenic human papillomavirus (HPV) initiated a quarter century of laboratory and epidemiological studies that demonstrated their necessary, but not sufficient, aetiological role in cervical and several other ano …
The discovery of genotype 16 as the prototype oncogenic human papillomavirus (HPV) initiated a quarter century of labor …
Approaching a decade since HPV vaccine licensure: Racial and gender disparities in knowledge and awareness of HPV and HPV vaccine.
Adjei Boakye E, Tobo BB, Rojek RP, Mohammed KA, Geneus CJ, Osazuwa-Peters N. Adjei Boakye E, et al. Hum Vaccin Immunother. 2017 Nov 2;13(11):2713-2722. doi: 10.1080/21645515.2017.1363133. Epub 2017 Aug 30. Hum Vaccin Immunother. 2017. PMID: 28853980 Free PMC article.
Purpose: Gaps remain in the public's knowledge of the human papillomavirus (HPV). We assessed racial/ethnic and gender disparities in knowledge and awareness of HPV and the HPV vaccine among US adults. METHODS: Data from the Health
Purpose: Gaps remain in the public's knowledge of the human papillomavirus (HPV). We assessed racial/ethnic and …
Cervical Cancer Screening Programs in Europe: The Transition Towards HPV Vaccination and Population-Based HPV Testing.
Chrysostomou AC, Stylianou DC, Constantinidou A, Kostrikis LG. Chrysostomou AC, et al. Viruses. 2018 Dec 19;10(12):729. doi: 10.3390/v10120729. Viruses. 2018. PMID: 30572620 Free PMC article. Review.
With the identification of the human papillomavirus (HPV) as the causative agent of essentially all cervical cancer cases, HPV molecular screening tests and HPV vaccines for primary prevention against the virus have been developed. …
With the identification of the human papillomavirus (HPV) as the causative agent of essentially all cervical cancer cas …
Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices.
Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE. Meites E, et al. MMWR Morb Mortal Wkly Rep. 2019 Aug 16;68(32):698-702. doi: 10.15585/mmwr.mm6832a3. MMWR Morb Mortal Wkly Rep. 2019. PMID: 31415491 Free PMC article.
Vaccination against human papillomavirus (HPV) is recommended to prevent new HPV infections and HPV-associated diseases, including some cancers. ...In June 2019, ACIP recommended catch-up HPV vaccination for all persons through age …
Vaccination against human papillomavirus (HPV) is recommended to prevent new HPV infections and HPV
Effect of Prophylactic Human Papillomavirus (HPV) Vaccination on Oral HPV Infections Among Young Adults in the United States.
Chaturvedi AK, Graubard BI, Broutian T, Pickard RKL, Tong ZY, Xiao W, Kahle L, Gillison ML. Chaturvedi AK, et al. J Clin Oncol. 2018 Jan 20;36(3):262-267. doi: 10.1200/JCO.2017.75.0141. Epub 2017 Nov 28. J Clin Oncol. 2018. PMID: 29182497 Free PMC article.
Purpose The incidence of human papilloma virus (HPV)-positive oropharyngeal cancers has risen rapidly in recent decades among men in the United States. ...Methods We conducted a cross-sectional study of men and women 18 to 33 years of age (N = 2,627) within the Nati …
Purpose The incidence of human papilloma virus (HPV)-positive oropharyngeal cancers has risen rapidly in recent decades among …
Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial.
Ogilvie GS, van Niekerk D, Krajden M, Smith LW, Cook D, Gondara L, Ceballos K, Quinlan D, Lee M, Martin RE, Gentile L, Peacock S, Stuart GCE, Franco EL, Coldman AJ. Ogilvie GS, et al. JAMA. 2018 Jul 3;320(1):43-52. doi: 10.1001/jama.2018.7464. JAMA. 2018. PMID: 29971397 Free PMC article. Clinical Trial.
IMPORTANCE: There is limited information about the relative effectiveness of cervical cancer screening with primary human papillomavirus (HPV) testing alone compared with cytology in North American populations. ...Women in the control group who …
IMPORTANCE: There is limited information about the relative effectiveness of cervical cancer screening with primary human p
The Effect of Vaccination Against Human Papillomavirus on Fecundability.
McInerney KA, Hatch EE, Wesselink AK, Mikkelsen EM, Rothman KJ, Perkins RB, Wise LA. McInerney KA, et al. Paediatr Perinat Epidemiol. 2017 Nov;31(6):531-536. doi: 10.1111/ppe.12408. Epub 2017 Sep 7. Paediatr Perinat Epidemiol. 2017. PMID: 28881394 Free PMC article.
BACKGROUND: The human papillomavirus (HPV) vaccine was developed to prevent infection with strains of HPV that cause cervical cancer. ...We hypothesize that HPV prevention via vaccination will protect fecundity. METHODS: We analyse …
BACKGROUND: The human papillomavirus (HPV) vaccine was developed to prevent infection with strains of HPV
555 results
Jump to page
Feedback